The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma
Open accessAbstract
PET gene reporter imaging can be used to monitor the trafficking of therapeutic cytotoxic T cells in glioma patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
Grupp, S. A., Kalos, M., Barrett, D., Aplenc, R., Porter, D. L., Rheingold, S. R., Teachey, D. T., Chew, A., Hauck, B., Wright, J. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215134 · Cited by 3,509
Wolchok, J. D., Hoos, A., O'Day, S., Weber, J. S., Hamid, O., Lebbé, C., Maio, M., Binder, M., Bohnsack, O., Nichol, G., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1624 · Cited by 3,222
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
Combining immunotherapy and targeted therapies in cancer treatment
Vanneman, M., & Dranoff, G. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3237 · Cited by 1,586
Brown, C. E., Badie, B., Barish, M. E., Weng, L., Ostberg, J. R., Chang, W.-C., Naranjo, A., Starr, R., Wagner, J., Wright, C., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0428 · Cited by 764
Self-citationNishino, M., Giobbie-Hurder, A., Gargano, M., Suda, M., Ramaiya, N. H., & Hodi, F. S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0895 · Cited by 522
Noninvasive cell-tracking methods
Kircher, M. F., Gambhir, S. S., & Grimm, J. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.141 · Cited by 501
Self-citationCTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma
Prieto, P. A., Yang, J. C., Sherry, R. M., Hughes, M. S., Kammula, U. S., White, D. E., Levy, C. L., Rosenberg, S. A., & Phan, G. Q. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1823 · Cited by 477
New approaches for imaging tumour responses to treatment
Brindle, K. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2289 · Cited by 460
Gambhir, S. S., Bauer, E., Black, M. E., Liang, Q., Kokoris, M. S., Barrio, J. R., Iyer, M., Namavari, M., Phelps, M. E., & Herschman, H. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.6.2785 · Cited by 450
Self-citationIn vivo MRI cell tracking: clinical studies
Bulte, J. W. M. (2009) · American Journal of Roentgenology · doi:10.2214/ajr.09.3107 · Cited by 430
Kahlon, K. S., Brown, C., Cooper, L. J. N., Raubitschek, A., Forman, S. J., & Jensen, M. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0454 · Cited by 368
Self-citationNoninvasive detection of therapeutic cytolytic T cells with 18F–FHBG PET in a patient with glioma
Yaghoubi, S. S., Jensen, M. C., Satyamurthy, N., Budhiraja, S., Paik, D., Czernin, J., & Gambhir, S. S. (2009) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1278 · Cited by 366
Self-citationImaging Transgene Expression with Radionuclide Imaging Technologies
Gambhir, S. S., Herschman, H. R., Cherry, S. R., Barrio, J. R., Satyamurthy, N., Toyokuni, T., Phelps, M. E., Larson, S. M., Balatoni, J., Finn, R., et al. (2000) · Neoplasia · doi:10.1038/sj.neo.7900083 · Cited by 358
Self-citationCD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma
Dudley, M. E., Gross, C. A., Langhan, M. M., Garcia, M. R., Sherry, R. M., Yang, J. C., Phan, G. Q., Kammula, U. S., Hughes, M. S., Citrin, D. E., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1297 · Cited by 315
Pak, K., Cheon, G. J., Nam, H.-Y., Kim, S.-J., Kang, K. W., Chung, J.-K., Kim, E. E., & Lee, D. S. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.133801 · Cited by 301
Gelovani, J. G., Doubrovin, M., Akhurst, T., Cai, S., Balatoni, J., Alauddin, M. M., Finn, R. D., Bornmann, W. G., Thaler, H. T., Conti, P. S., et al. (2002) · PubMed · Cited by 270
Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas.
Debinski, W., Gibo, D. M., Hulet, S. W., Connor, J. R., & Gillespie, G. Y. (1999) · PubMed · Cited by 254
Yaghoubi, S. S., Barrio, J. R., Dahlbom, M. L., Iyer, M. R., Namavari, M., Satyamurthy, N., Goldman, R. B., Herschman, H. R., Phelps, M. E., & Gambhir, S. S. (2001) · PubMed · Cited by 230
Self-citationBrown, C. E., Starr, R., Aguilar, B., Shami, A. F., Martinez, C., D'Apuzzo, M., Barish, M. E., Forman, S. J., & Jensen, M. C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1669 · Cited by 225
Self-citationMountz, J., Ahmed, R., Oborski, M., Lieberman, F., & Hwang, M. (2014) · Cancer Management and Research · doi:10.2147/cmar.s54726 · Cited by 208
Acquired and intrinsic resistance in cancer immunotherapy
Kelderman, S., Schumacher, T. N. M., & Haanen, J. B. A. G. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.011 · Cited by 197
Schuessler, A., Smith, C., Beagley, L., Boyle, G. M., Rehan, S., Matthews, K., Jones, L., Crough, T., Dasari, V., Klein, K., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0296 · Cited by 179
Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis
Brown, C. E., Warden, C. D., Starr, R., Deng, X., Badie, B., Yuan, Y.-C., Forman, S. J., & Barish, M. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077769 · Cited by 166
Self-citationQuantitative imaging of the T cell antitumor response by positron-emission tomography
Dubey, P., Su, H. C., Adonai, N., Du, S., Rosato, A., Braun, J. G., Gambhir, S. S., & Witte, O. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337418100 · Cited by 154
Self-citationJuratli, T. A., Schackert, G., & Krex, D. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.05.003 · Cited by 149
Prognostic Significance of Volume-Based PET Parameters in Cancer Patients
Moon, S. H., Hyun, S. H., & Choi, J. Y. (2013) · Korean Journal of Radiology · doi:10.3348/kjr.2013.14.1.1 · Cited by 139
Yaghoubi, S. S., & Gambhir, S. S. (2006) · Nature Protocols · doi:10.1038/nprot.2006.459 · Cited by 130
Self-citationFinke, L. H., Wentworth, K., Blumenstein, B. A., Rudolph, N. S., Levitsky, H. I., & Hoos, A. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.06.067 · Cited by 121
Comparison of three different methods for radiolabelling human activated T lymphocytes
Botti, C., Negri, D. R. M., Seregni, E. C., Ramakrishna, V., Arienti, F., Maffioli, L. S., Lombardo, C., Bogni, A., Pascali, C., Crippa, F., et al. (1997) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf01267680 · Cited by 88
Molecular PET imaging of HSV1-tk reporter gene expression using [18F]FEAU
Soghomonyan, S., Hajitou, A., Rangel, R., Trepel, M., Pasqualini, R., Arap, W., Gelovani, J. G., & Alauddin, M. M. (2007) · Nature Protocols · doi:10.1038/nprot.2007.49 · Cited by 70
Kim, Y., Dubey, P., Ray, P., Gambhir, S. S., & Witte, O. N. (2004) · Molecular Imaging and Biology · doi:10.1016/j.mibio.2004.06.009 · Cited by 66
Self-citationQi, C., Ning, Y., Han, Y.-S., Min, H.-Y., Ye, H., Zhu, Y.-L., & Qian, K. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1192-2 · Cited by 65
Adoptive Cell Therapies for Glioblastoma
Bielamowicz, K., Khawja, S. N., & Ahmed, N. M. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00275 · Cited by 56
Molecular Imaging of PET Reporter Gene Expression
Min, J., & Gambhir, S. S. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-77496-9_12 · Cited by 50
Self-citationTracking Cellular and Immune Therapies in Cancer
Kurtz, D. M., & Gambhir, S. S. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-411638-2.00008-2 · Cited by 27
Self-citationLuker, G. D., Luker, K. E., Sharma, V., Pica, C. M., Dahlheimer, J. L., Ocheskey, J. A., Fahrner, T. J., Milbrandt, J., & Piwnica-Worms, D. R. (2002) · Molecular Imaging · doi:10.1162/15353500200201118 · Cited by 21
Olivier, A., Petyt, G., Cortot, A. B., et al. (2014) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000145 · Cited by 17
Cited by
The blood–brain barrier and blood–tumour barrier in brain tumours and metastases
Arvanitis, C. D., Ferraro, G. B., & Jain, R. K. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0205-x · Cited by 1,792
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
Albelda, S. M. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00832-4 · Cited by 517
Chao, Y., Xu, L., Liang, C., Feng, L., Xu, J., Dong, Z., Tian, L., Yi, X., Yang, K., & Liu, Z. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0262-6 · Cited by 493
ImmunoPET: Concept, Design, and Applications
Wei, W., Rosenkrans, Z. T., Liu, J., Huang, G., Luo, Q.-Y., & Cai, W. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00738 · Cited by 484
CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors
Jin, L., Tao, H., Karachi, A., Long, Y., Hou, A. Y., Na, M., Dyson, K. A., Grippin, A. J., Deleyrolle, L. P., Zhang, W., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11869-4 · Cited by 385
Metadata
- Authors
- Keu, K. V., Witney, T. H., Yaghoubi, S., Rosenberg, J., Kurien, A., Magnusson, R., Williams, J., Habte, F., Wagner, J. R., Forman, S., Brown, C., Allen-Auerbach, M., Czernin, J., Tang, W., Jensen, M. C., Badie, B., & Gambhir, S. S.
- Venue
- Science Translational Medicine
- Published
- 2017-01-18
- Volume
- 9
- Issue
- 373
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2575232561
- Cited by
- 319
- References
- 43
- FWCI
- 24.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.